Volume 17 - Issue 8 - August 2004
Many lesions of bone that arise with relative frequency in the feet are seen less commonly in alternate locations. Similarly, there are a host of trends with regard to the biology of bone tumors that are unique to the distal extremities, particularly the feet. With that said, let’s review the most common malignant tumors of the bones of the feet and key clinical features that can aid in arriving at the most appropriate diagnosis and subsequent treatment.
While it is far from the most common malignant tumor of the skeletal system at large, Ewing’s sarcoma/primitive neuroectodermal tumor (P
Yes, Neal Blitz, DPM, says it is possible in certain cases. In assessing the literature and his own experience, he emphasizes proper patient selection and key surgical tips for facilitating optimal outcomes.
The Lapidus arthrodesis is an excellent procedure to correct metatarsus primus adductus. The procedure, which allows one to realign and stabilize the first metatarsal at the apex of the deformity, was first described by Albrecht in 1911 and subsequently popularized by Lapidus.1-4 Yet it was later abandoned by many surgeons because of the high nonunion rate and postoperative c
The clock is ticking. In another step of a process which began in 1996, the Centers for Medicare and Medicaid Services have set a deadline of April 21, 2005 for compliance with the security standards of the Health Insurance Portability and Accountability Act (HIPAA). Is your practice ready to meet the deadline?
The voluminous data on HIPAA compliance lays out broad guidelines for maintaining security. As the final rule from the Federal Register states, healthcare organizations must “ensure the confidentiality, integrity and availability of all electronically protected health informat
Continuing Education »
Charcot neuroarthropathy and the complications of longstanding diabetes are perhaps the greatest challenge for the foot and ankle specialist. These conditions are of principal concern given the limb threatening consequences when a diagnosis of Charcot foot is delayed or missed completely. Though there is no modern revelation in identifying the Charcot foot, there has been rejuvenated interest behind the continued study of this neuropathic entity.1-22 Subsequently, the slow rise in the number of reported cases of Charcot neuroarthropathy is likely due more to increased awareness
Intriguing new treatments and devices abound in this yearly review. We take a closer look at promising therapies for diabetic neuropathy and osteoarthritis of the ankle. Wound care specialists weigh in on new approaches to optimizing wound beds and closing stubborn wounds. Podiatric surgeons discuss time-saving devices for facilitating tendon transfers and leading voices in biomechanics offer their respective takes on a helpful orthotic modification, a re-emerging pediatric orthotic and a new athletic shoe that is generating a lot of buzz.
Without further delay, here is what the experts had t
I enjoyed finally being able to see patients in my third year of podiatry school. The college clinic was clogged with students in white coats and a few patients. Most students were considered fortunate if they cared for one patient on a typical clinic day.
I always dragged neighbors from my East Cleveland apartment complex where I worked as a night maintenance man. While I fixed their appliances and unclogged their plumbing, I always inquired about any foot problems. I usually saw at least five patients every clinic day.
Since I developed my rapport with these patients as neighbors, they add